XPH

SPDR$64.02-0.14 (-0.21%)
AUM $444.2MER 0.35%NAV $62.13Holdings 62

Price Chart

Key Statistics

Previous Close

$64.15

Day Range

$63.87$64.64

52-Week Range

$48.30$74.06

Avg Volume

233.8K

Dividend Yield

0.84%

Expense Ratio

0.35%

AUM

$444.2M

Shares Outstanding

4.0M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States95.73%
Ireland4.18%
Other0.09%

Fund Information

Issuer
SPDR
Category
Healthcare
Inception Date
Jun 19, 2006
Exchange
NYSE_ARCA
Description
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$44.84B
VHTVanguard Health Care ETF$21.80B
VTWOVanguard Russell 2000 ETF$17.30B
RWLInvesco S&P 500 Revenue ETF$10.09B
XBIState Street SPDR S&P Biotech ETF$10.07B

The State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund issued by SPDR that launched on Jun 19, 2006. It currently manages $444.2M in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 62 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 23.3% of the fund

RankSymbolNameWeight %SharesMarket Value
1XERSXERIS BIOPHARMA HOLDINGS INC2.68%1,199,641$11.9M
2PCRXPACIRA BIOSCIENCES INC2.60%322,357$11.5M
3MANEVERADERMICS INC2.37%92,805$10.5M
4PRGOPERRIGO CO PLC2.36%644,991$10.5M
5AMRXAMNEAL PHARMACEUTICALS INC2.29%536,189$10.2M
6LLYELI LILLY + CO2.28%8,218$10.1M
7VTRSVIATRIS INC2.26%560,560$10.1M
8ZTSZOETIS INC2.19%126,160$9.7M
9PFEPFIZER INC2.17%332,947$9.7M
10LGNDLIGAND PHARMACEUTICALS2.12%32,102$9.4M
11ANIPANI PHARMACEUTICALS INC2.10%130,831$9.3M
12PBHPRESTIGE CONSUMER HEALTHCARE2.07%189,919$9.2M
13OGNORGANON + CO2.06%676,602$9.2M
14ELANELANCO ANIMAL HEALTH INC2.05%392,747$9.1M
15MAZEMAZE THERAPEUTICS INC2.04%334,807$9.1M
Page 1 of 2

Detailed Returns

PeriodReturnETF
1D
-0.21%
1W
+3.04%
1M
-7.01%
3M
-5.87%
6M
+10.47%
YTD
+15.85%
1Y
+31.88%
3Y
+76.73%
5Y
+33.03%

Moving Averages

20-Day MA

$63.95

Above 20-Day MA
50-Day MA

$67.64

Below 50-Day MA
200-Day MA

$61.46

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$74.06

Current Price

$64.02

52-Week Low

$48.30

$48.30$74.06

Current Yield

0.84%

Annual Dividend

$0.2747

Frequency

4x/year

Last Ex-Date

Sep 21, 2026

Dividend History

Ex-DateAmountPay Date
Sep 21, 2026$0.0416Sep 23, 2026
Jun 22, 2026$0.0590Jun 24, 2026
Mar 23, 2026$0.0610Mar 25, 2026
Dec 22, 2025$0.1130Dec 24, 2025
Dec 22, 2025$0.1130Dec 24, 2025
Sep 22, 2025$0.1026Sep 24, 2025
Sep 22, 2025$0.1026Sep 24, 2025
Jun 23, 2025$0.0959Jun 25, 2025
Mar 24, 2025$0.1533Mar 26, 2025
Mar 24, 2025$0.1533Mar 26, 2025
Dec 23, 2024$0.1548Dec 26, 2024
Dec 23, 2024$0.1548Dec 26, 2024
Sep 23, 2024$0.1947Sep 25, 2024
Sep 23, 2024$0.1947Sep 25, 2024
Jun 24, 2024$0.1557Jun 26, 2024
Jun 24, 2024$0.1557Jun 26, 2024
Mar 18, 2024$0.1730Mar 21, 2024
Mar 18, 2024$0.1730Mar 21, 2024
Dec 18, 2023$0.1744Dec 21, 2023
Dec 18, 2023$0.1744Dec 21, 2023

Dividend Payments Over Time

Category Comparison

MetricXPHHealthcare(205 ETFs)Equal Weight(109 ETFs)
Fund Info
Expense Ratio0.35%0.64%0.68%
AUM$444.2M$868.4M$1.73B
Dividend Yield0.84%4.50%2.87%
Avg Volume233.8K264.1K579.7K
Holdings62145192
Performance
1-Month Return-7.01%-1.96%-0.74%
6-Month Return+14.64%+10.01%+4.68%
YTD Return+14.19%+11.25%+12.54%
1-Year Return+14.64%+7.17%+8.80%

Compare with Another ETF

Search for an ETF to compare with XPH:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.